Related Experiment Videos

Pulmonary outcomes in bronchopulmonary dysplasia

Anita Bhandari1, Howard B Panitch

  • 1Division of Pediatric Pulmonology, University of Connecticut, Connecticut Children's Medical Center, Hartford, CT 06106, USA. Abhanda@ccmckids.org

Insights

Bronchopulmonary dysplasia (BPD) affects premature infants, causing lasting lung issues and frequent hospitalizations. While some lung function improves, small airway problems and radiological changes persist, necessitating ongoing monitoring.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Respiratory Medicine

Background:

  • Bronchopulmonary dysplasia (BPD) affects approximately 30% of infants born weighing less than 1000 grams.
  • BPD is characterized by persistent lung structural changes impacting mechanics, gas exchange, and pulmonary vasculature.
  • Infants with BPD face a high risk of readmission due to lower respiratory tract illnesses.

Purpose of the Study:

  • To review the long-term pulmonary sequelae in infants diagnosed with bronchopulmonary dysplasia.
  • To understand the dynamic processes involved in BPD development, including inflammation, injury, repair, and maturation.
  • To emphasize the critical need for continued surveillance of young adults with a history of BPD.

Main Methods:

  • Review of existing literature and long-term patient data.
  • Analysis of pulmonary mechanics, lung volumes, and gas exchange over time.
  • Assessment of radiological findings and exercise capacity in individuals with BPD.

Main Results:

  • Pulmonary mechanics and some lung volumes normalize with growth, but small airway dysfunction persists.
  • Most individuals do not experience long-term decreases in exercise capacity.
  • Mild to moderate radiological abnormalities are common and persist long-term.

Conclusions:

  • Bronchopulmonary dysplasia results from complex inflammatory and repair processes.
  • Individuals with BPD experience significant pulmonary issues throughout childhood and adolescence.
  • Long-term surveillance is essential for managing the pulmonary sequelae of BPD into adulthood.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation